SCHEMBL27779441

SCHEMBL27779441

CC(C)(C)C(=O)Oc1c[nH]c2cc(Cl)c(CCBr)cc12

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR1D P28221 1/20 0.40
HTR1B P28222 1/20 0.40
MTNR1A P48039 4/20 0.38
MTNR1B P49286 4/20 0.38
MEN1 O00255 2/20 0.38
CYP1A2 P05177 2/20 0.38
CYP3A4 P08684 2/20 0.38
CYP2C19 P33261 2/20 0.38
KMT2A Q03164 2/20 0.38
LMNA P02545 1/20 0.38
CYP2D6 P10635 1/20 0.38
CYP2C9 P11712 1/20 0.38
NFKB1 P19838 1/20 0.38
MAPK1 P28482 1/20 0.38
SLC6A4 P31645 1/20 0.38
THPO P40225 1/20 0.38
HTR2B P41595 1/20 0.38
HIF1A Q16665 1/20 0.38
MAPT P10636 2/20 0.35
PRKAB2 O43741 6/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27601675 0.90 HTR1D (0.39) HTR1DHTR1BMTNR1AMTNR1BMEN1
SCHEMBL27800463 0.86 HTR1D (0.40) HTR1DHTR1BMTNR1AMTNR1BHTR2B
SCHEMBL27601684 0.80 HTR1D (0.37) HTR1DHTR1BMTNR1AMTNR1BMEN1
SCHEMBL27800471 0.79 HTR1D (0.35) HTR1DHTR1BCYP3A4LMNAHIF1A
SCHEMBL27584069 0.78 HTR1D (0.39) HTR1DHTR1BMTNR1AMTNR1BHTR2B
SCHEMBL27596759 0.78 HTR1D (0.46) HTR1DHTR1BELANESLC22A6
SCHEMBL27800472 0.76 HTR1D (0.40) HTR1DHTR1BMTNR1AMTNR1BCYP3A4
SCHEMBL28785936 0.76 HTR1D (0.33) HTR1DHTR1BCYP3A4LMNAHIF1A
SCHEMBL27800464 0.73 ALDH1A1 (0.41) HTR1DHTR1BMTNR1AMTNR1BMEN1
SCHEMBL27591784 0.73 NR4A2 (0.52) HTR1DHTR1BSLC6A4ELANESLC22A6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-101691370-A Triazolo[4,5-d] pyrimidine derivatives and their use as purinergic receptor antagonists VERNALIS RES LTD 2010-04-07 CN disclosed